325 related articles for article (PubMed ID: 29431654)
1. Enhanced Operant Extinction and Prefrontal Excitability in a Mouse Model of Angelman Syndrome.
Sidorov MS; Judson MC; Kim H; Rougie M; Ferrer AI; Nikolova VD; Riddick NV; Moy SS; Philpot BD
J Neurosci; 2018 Mar; 38(11):2671-2682. PubMed ID: 29431654
[TBL] [Abstract][Full Text] [Related]
2. Adult
Rotaru DC; van Woerden GM; Wallaard I; Elgersma Y
J Neurosci; 2018 Sep; 38(37):8011-8030. PubMed ID: 30082419
[TBL] [Abstract][Full Text] [Related]
3.
Wallace ML; van Woerden GM; Elgersma Y; Smith SL; Philpot BD
J Neurophysiol; 2017 Jul; 118(1):634-646. PubMed ID: 28468997
[TBL] [Abstract][Full Text] [Related]
4. Extinction of an instrumental response: a cognitive behavioral assay in Fmr1 knockout mice.
Sidorov MS; Krueger DD; Taylor M; Gisin E; Osterweil EK; Bear MF
Genes Brain Behav; 2014 Jun; 13(5):451-8. PubMed ID: 24684608
[TBL] [Abstract][Full Text] [Related]
5. Excessive Laughter-like Vocalizations, Microcephaly, and Translational Outcomes in the
Berg EL; Jami SA; Petkova SP; Berz A; Fenton TA; Lerch JP; Segal DJ; Gray JA; Ellegood J; Wöhr M; Silverman JL
J Neurosci; 2021 Oct; 41(42):8801-8814. PubMed ID: 34475199
[TBL] [Abstract][Full Text] [Related]
6. A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel
Sonzogni M; Wallaard I; Santos SS; Kingma J; du Mee D; van Woerden GM; Elgersma Y
Mol Autism; 2018; 9():47. PubMed ID: 30220990
[TBL] [Abstract][Full Text] [Related]
7. Region-specific impairments in striatal synaptic transmission and impaired instrumental learning in a mouse model of Angelman syndrome.
Hayrapetyan V; Castro S; Sukharnikova T; Yu C; Cao X; Jiang YH; Yin HH
Eur J Neurosci; 2014 Mar; 39(6):1018-1025. PubMed ID: 24329862
[TBL] [Abstract][Full Text] [Related]
8. Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity, Disproportional Reductions in White Matter Volume, and Microcephaly in Angelman Syndrome Model Mice.
Judson MC; Burette AC; Thaxton CL; Pribisko AL; Shen MD; Rumple AM; Del Cid WA; Paniagua B; Styner M; Weinberg RJ; Philpot BD
J Neurosci; 2017 Aug; 37(31):7347-7361. PubMed ID: 28663201
[TBL] [Abstract][Full Text] [Related]
9. Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities.
Leach PT; Crawley JN
Genes Brain Behav; 2018 Jul; 17(6):e12452. PubMed ID: 29266714
[TBL] [Abstract][Full Text] [Related]
10. Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome.
Sonzogni M; Zhai P; Mientjes EJ; van Woerden GM; Elgersma Y
Mol Autism; 2020 Sep; 11(1):70. PubMed ID: 32948244
[TBL] [Abstract][Full Text] [Related]
11. Behavioral deficits in an Angelman syndrome model: effects of genetic background and age.
Huang HS; Burns AJ; Nonneman RJ; Baker LK; Riddick NV; Nikolova VD; Riday TT; Yashiro K; Philpot BD; Moy SS
Behav Brain Res; 2013 Apr; 243():79-90. PubMed ID: 23295389
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Nociception in Angelman Syndrome Model Mice.
McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ
J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574
[TBL] [Abstract][Full Text] [Related]
13. Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes.
Sonzogni M; Hakonen J; Bernabé Kleijn M; Silva-Santos S; Judson MC; Philpot BD; van Woerden GM; Elgersma Y
Mol Autism; 2019; 10():23. PubMed ID: 31143434
[TBL] [Abstract][Full Text] [Related]
14. Angelman Syndrome: From Mouse Models to Therapy.
Rotaru DC; Mientjes EJ; Elgersma Y
Neuroscience; 2020 Oct; 445():172-189. PubMed ID: 32088294
[TBL] [Abstract][Full Text] [Related]
15. Hypersociability in the Angelman syndrome mouse model.
Stoppel DC; Anderson MP
Exp Neurol; 2017 Jul; 293():137-143. PubMed ID: 28411125
[TBL] [Abstract][Full Text] [Related]
16. Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice.
Born HA; Dao AT; Levine AT; Lee WL; Mehta NM; Mehra S; Weeber EJ; Anderson AE
Sci Rep; 2017 Aug; 7(1):8451. PubMed ID: 28814801
[TBL] [Abstract][Full Text] [Related]
17. Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the
Syding LA; Kubik-Zahorodna A; Nickl P; Novosadova V; Kopkanova J; Kasparek P; Prochazka J; Sedlacek R
Cells; 2022 Sep; 11(18):. PubMed ID: 36139390
[TBL] [Abstract][Full Text] [Related]
18. Abnormal electrophysiological phenotypes and sleep deficits in a mouse model of Angelman Syndrome.
Copping NA; Silverman JL
Mol Autism; 2021 Feb; 12(1):9. PubMed ID: 33549123
[TBL] [Abstract][Full Text] [Related]
19. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F
Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045
[TBL] [Abstract][Full Text] [Related]
20. Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion.
Dodge A; Peters MM; Greene HE; Dietrick C; Botelho R; Chung D; Willman J; Nenninger AW; Ciarlone S; Kamath SG; Houdek P; Sumová A; Anderson AE; Dindot SV; Berg EL; O'Geen H; Segal DJ; Silverman JL; Weeber EJ; Nash KR
Autism Res; 2020 Mar; 13(3):397-409. PubMed ID: 31961493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
